Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Edward Jenner
- Louis Pasteur
- Attenuated vaccines
- Daniel Elmer Salmon
- Inactivated vaccines
- The immune system is redundant
- Major licensed viral and bacterial vaccines
- Persistence of immunity after vaccination
- Fatal smallpox
- Severe smallpox
- Infants are difficult to immunize
- Measles
- The elderly are difficult to immunize
- Influenza vaccine effectiveness
- Herd immunity
- Pediatric pneumococcal conjugate vaccination
- Rotavirus vaccine
- Burden of Rotavirus disease in the United States
- Reconstructed image of the Rotavirus particle
- Bovine (WC3) Rotavirus
- Safety of pentavalent Rotavirus vaccine
- G-serotype phase III safety and efficacy study
- Influenza vaccines
- Heterovariant protection by intranasal flu vaccine
- Influenza vaccine efficacy
- School-based intranasal influenza vaccination
- Zoster vaccine
- Herpes zoster incidence and CD4 memory
- Study of zoster vaccine
- Human Papillomavirus vaccine
- HPV and cancer
- The L1 protein
- Gardasil: phase 3 prophylactic efficacy results
- Newer strategies for vaccine development (1)
- Newer strategies for vaccine development (2)
- Parainfluenza recombinant vaccine
- Bovine/human PIV3/RSV immunization
- Vectors
- CMV CTL response to Canarypox-pp65 vector
- DNA plasmid vaccination
- SHIV viral load
- "Reverse vaccinology"
- Non-parenteral routes of administration
- TCI: antigen and adjuvant delivery via a patch
- Methods of transcutaneous immunization
- Macroflux(R) patch: comparison to 25 g needle
- New meningococcal vaccines
- Advantages of conjugated meningococcal vaccine
- Malaria vaccines
- Kaplan-Meier curves
- TB vaccines
- HIV vaccines
- H5N1
- Some strategies for H5N1 influenza vaccine
- The 21st century vaccinology main problems
Topics Covered
- History of vaccines, with four lessons of vaccinology
- New vaccines, including those against rotavirus, influenza, zoster and human papillomaviruses
- New strategies of vaccine development, including recombinants, vectors, plasmid DNA and non|parenteral routes of administration
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Plotkin, S. (2007, October 1). The past, present and future of vaccination [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 8, 2024, from https://doi.org/10.69645/HYML1712.Export Citation (RIS)
Publication History
Financial Disclosures
- Stanley Plotkin consults for Sanofi, Merck, GSK, Pfizer and Takeda